Webcast: Portfolio analysis - Tracking for success

Melinda Shorr - Dec 2017

Portfolio Analysis and Optimization looks at how honing strategy across multiple agents in the same therapeutic category leads to marketing success. As pharmaceutical companies simultaneously develop and in-license multiple products that can cost millions of dollars, portfolio management is about selecting how to allocate resources and marketing efforts across multiple assets. This has significant impact on the bottom line. 

Portfolio analysis 2019
Portfolio analysis 2019

Portfolio Analysis and Optimization looks at how honing strategy across multiple agents in the same therapeutic category leads to marketing success. As pharmaceutical companies simultaneously develop and in-license multiple products that can cost millions of dollars, portfolio management is about selecting how to allocate resources and marketing efforts across multiple assets. This has significant impact on the bottom line. 

Watch this webcast in which our experts present this second webinar in a three part series which is designed to provide clarity when maximizing resources within a category-specific portfolio. The series will cover three main topics:

1. Communication strategy
2. Tracking inputs
3. Go-no/go decisions

The first in the series (which is now available as a webcast) looked at communications strategy. This webinar covers portfolio tracking for success and the third webinar in December 2019 will show you how research can support go or no-go decisions in portfolio planning.

What are the key takeaways?

  • Defining performance tracking in portfolio optimization: Presenters will begin by discussing how best to measure and monitor individual asset’s performance in a therapeutic portfolio to evaluate the current and ongoing market position.

  • Alignment: Next, we will explore how best to ensure stakeholder agreement, including mining internal knowledge to set measures for tracking and to understand current portfolio and asset dynamics.

  • Setting timeframes for reporting to support individual assets and
    portfolio needs:
    Finally, the presenters will explain how to determine optimum points in time and data visualised outputs for asset-level readouts, as well as identifying needs for continuous reporting of overall findings and specific metrics. 

  • Question and answer session:
    Following the presentation there will be a live Q&A where they will address any specific challenges you have encountered or concerns you may have about conducting portfolio analysis studies. We welcome you to submit your questions in advance when you register.

Sign up to receive Rapport

Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research.

Sign up here